THE FEDERAL Government has announced lenalidomide (Revlimid) will be added to the Pharmaceutical Benefits Scheme (PBS) from 1 November 2009.
13/10/2009
AS OF the 1 September 2009, patients treating their HIV with antiretroviral medication life is set to improve with the Pharmaceutical Benefits Scheme (PBS) listing of a therapy which helps correct HIV-associated facial lipoatrophy (facial fat loss).
04/09/2009
THE LIFE Technologies Foundation, a non-profit arm of Life Technologies has awarded approximately $1.7 million in new grants which include the creation of an online biology textbook, and building a museum exhibit about the human cell.
02/10/2009